Skip to main content
. 2020 Aug 18;12(8):2332. doi: 10.3390/cancers12082332

Figure 1.

Figure 1

The methylation levels of SCAND3 and Myo1g in seven hepatocellular carcinoma (HCC) cell lines and the normal hepatocyte cell line LO2. (A) SCAND3 average methylation levels in seven HCC cell lines (HepG2, HepB3, MHCC97H, MHCC97L, SK-Hep-1, Huh7, PLC) and LO2 were 92.07%, 90.53%, 89.23%, 93.64%, 91.60%, 61.73%, 94.07%, 8.07%, respectively. (B) Myo1g average methylation levels in seven HCC cell lines (HepG2, HepB3, MHCC97H, MHCC97L, SK-Hep-1, Huh7, PLC) and LO2 were 29.73%, 87.00%, 94.10%, 65.17%, 96.96%, 89.30%, 87.37%, 14.47%, respectively. SCAND3 and Myo1g hypermethylation were more prominent in seven HCC cell lines than in LO2. Statistical comparisons were computed using the unpaired t-test, * p < 0.05.